Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180733
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2023-12-04
Brief Title:
Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-04
First Submit QC Date:
December 12 2023
Study First Post Date:
2023-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-12
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL